Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.26
Bid: 52.26
Ask: 52.28
Change: 1.06 (2.07%)
Spread: 0.02 (0.038%)
Open: 51.12
High: 52.60
Low: 51.08
Prev. Close: 51.20
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consent Solicitation Announcement

29 Sep 2020 10:55

RNS Number : 4474A
Lloyds Banking Group PLC
29 September 2020
 

FOR DISTRIBUTION ONLY OUTSIDE THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS TO PERSONS OTHER THAN "U.S. PERSONS" (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.

29 September 2020

LLOYDS BANKING GROUP PLC

(incorporated in Scotland with limited liability under registered number 95000)

Legal Entity Identifier (LEI: H7FNTJ4851HG0EXQ1Z70)

 (the "Issuer")

NOTICE

to the holders of the

£1,494,392,000 7.625 per cent. Fixed Rate Reset Additional Tier 1 Perpetual Subordinated Contingent Convertible Securities Callable 2023 (ISIN: XS1043552188) (the "PNC9 Securities")

£750,009,000 7.875 per cent. Fixed Rate Reset Additional Tier 1 Perpetual Subordinated Contingent Convertible Securities Callable 2029 (ISIN: XS1043552261) (the "PNC15 Securities") (each a "Series" and together the "Securities", and the holders thereof, the "Securityholders") of the Issuer presently outstanding.

The Issuer has today given a Notice of Meetings in respect of the Securities for the purpose of soliciting consent from the Securityholders to the modification of the terms and conditions (the "Conditions") of the relevant Series and consequential or related amendments to the transaction documents for the relevant Series of Securities such that (i) the Reset Reference Rate (as defined in the relevant Conditions) ceases to be a London Inter Bank Offered Rate ("LIBOR") linked mid-swap rate and becomes a Sterling Overnight Index Average ("SONIA") linked mid-swap rate; (ii) an adjustment (the "Reset Reference Rate Adjustment") is made to reflect the economic difference between the LIBOR and SONIA rates; and (iii) the Margin (as defined in the relevant Conditions) applicable to each Series of Securities remains unaltered; (iv) the fallbacks relating to the Reset Reference Rate are amended; and (v) new fallbacks are included in case a Benchmark Event (as defined in the Consent Solicitation Memorandum) occurs with respect to the Reset Rate of Interest, as proposed by the Issuer for approval by a separate extraordinary resolution of the holders of each such Series (each an "Extraordinary Resolution"), all as further described in the consent solicitation memorandum dated 29 September 2020 (the "Consent Solicitation Memorandum") (each such invitation a "Consent Solicitation").

In light of the ongoing developments in relation to coronavirus (COVID-19), and current guidance issued by the UK government, it may become impossible or inadvisable to hold each relevant Meeting at a physical location. Accordingly, in accordance with the provisions of the relevant Trust Deed the Issuer has requested that the Trustee prescribe appropriate regulations regarding the holding of the relevant Meeting via teleconference.

1. Notice of meetingS in respect of the SECURITIES

The Notice of Meeting will be available for viewing at the Issuer's website:

https://www.lloydsbankinggroup.com/investors/fixed-income-investors/consent-solicitation

 

2. Indicative timetable for the consent solicitation

Set out below is an indicative timetable showing one possible outcome for the timing of the Consent Solicitations, which will depend, among other things, on timely receipt (and non revocation) of instructions, the rights of the Issuer (where applicable) to extend, waive any condition of, amend and/or terminate either Consent Solicitation (other than the terms of the relevant Extraordinary Resolution) as described in the Consent Solicitation Memorandum and the passing of each Extraordinary Resolution at the initial Meeting for the relevant Series. Accordingly, the actual timetable may differ significantly from the timetable below.

Date/Time

 

Action

29 September 2020

(At least 21 clear days before the Meeting)

1.

Notice of the Meetings to be delivered to the Clearing Systems.

Release of Notice through the regulatory news service of the London Stock Exchange.

 

 

Copies of the Consent Solicitation Memorandum to be available from the Tabulation Agent and the Securityholder Information (as defined in the Notice) to be available for inspection, as indicated, at the specified office of the Principal Paying and Conversion Agent and on the website of the Issuer (https://www.lloydsbankinggroup.com/investors/fixed-income-investors/consent-solicitation ) (the "Issuer's Website"). From this date, Securityholders may arrange for Securities held by Clearstream, Luxembourg and/or Euroclear in their accounts to be blocked in such accounts and held to the order and under the control of the Principal Paying and Conversion Agent in order to obtain a form of proxy or give valid Consent Instructions or Ineligible Holder Instructions, to the Tabulation Agent.

By 10 a.m.(London time) (11 a.m. CET)

on 19 October 2020

(At least 48 hours before the Meeting)

2.

Expiration Deadline.

Final time by which Securityholders have arranged for:

(i) obtaining a form of proxy from the Principal Paying and Conversion Agent in order to attend (via teleconference) and vote at the relevant Meeting; or

(ii) receipt by the Tabulation Agent of valid Consent Instructions or Ineligible Holder Instructions in accordance with the procedures of Clearstream, Luxembourg and/or Euroclear.

 

3.

Final time by which Securityholders have given notice to the Tabulation Agent (via the relevant Clearing Systems) of any intended revocation of, or amendment to, Consent Instructions or Ineligible Holder Instructions previously given by them.

10 a.m. (London time) (11 a.m. CET)

on 21 October 2020

4.

SECURITYHOLDERS' MEETING HELD

The initial Meeting in respect of:

(i) the PNC9 Securities will commence at 10.00 a.m. (London time) (11.00 a.m. CET); and

(ii) the PNC15 Securities will commence at 10.15 a.m. (London time) (11.15 a.m. CET) or after the completion of the PNC9 Securities Meeting (whichever is later).

If the relevant Extraordinary Resolutions are passed at the relevant Meeting:

As soon as reasonably practicable after the Meetings

5.

Announcement of the results of the Meetings and, if the relevant Extraordinary Resolution is passed, satisfaction (or not) of the Eligibility Condition.

Delivery of notice of such results to Euroclear and Clearstream, Luxembourg for communication to their account holders and an announcement released on the regulatory news service of the London Stock Exchange.

At or around 2 p.m. (London time) (3 p.m. CET)

on 21 October 2020

(the "Pricing Date")

6.

Pricing Time and Pricing Date

Solicitation Agent to calculate the relevant Reset Reference Rate Adjustment in respect of each Series.

A pricing announcement will be delivered through the Clearing Systems and released through the regulatory news service of the London Stock Exchange as soon as practicable following the Pricing Time on the Pricing Date.

21 October 2020

(the "Effective Date")

7.

If the relevant Extraordinary Resolution is passed at the relevant initial Meeting (or at a subsequent adjourned Meeting) and the Eligibility Condition is satisfied, the relevant Supplemental Trust Deed will be executed by the Issuer and the Trustee and the modifications to the Conditions of the relevant Series described in the Consent Solicitation Memorandum will be implemented with effect on and from 21 October 2020 (the "Effective Date")

If a quorum is not achieved at a Meeting or the quorum is achieved and the relevant Extraordinary Resolution is passed but the Eligibility Condition is not satisfied, such Meeting shall be adjourned and the adjourned Meeting of Securityholders for that Series will be held at a date as will be notified to the Securityholders in the notice of the adjourned Meeting.

The unaudited interim condensed consolidated financial statements of the Issuer for the nine months ended 30 September 2020 (the "Interim Results") are expected to be published on 29 October 2020. In case an adjourned Meeting is to be held, investors will be entitled to revoke their instructions with

effect from the date on which a notice of adjournment is issued and such adjourned Meeting will be

held on a date following publication of the Interim Results which will allow for sufficient time for

investors to provide voting instructions post publication of the Interim Results. 

The adjourned Meeting will be held in accordance with the terms of the relevant Trust Deed. If the relevant Extraordinary Resolution is passed at the adjourned Meeting and the Eligibility Condition is satisfied in respect of the relevant Series, the relevant Supplemental Trust Deed will be executed by the Issuer and the Trustee and the modifications with respect to such Series described in the Consent Solicitation Memorandum will be implemented on the Effective Date.

Securityholders are advised to check with any bank, securities broker or other intermediary through which they hold Securities when such intermediary would need to receive instructions from a Securityholder in order for that Securityholder to be able to participate in, or revoke their instruction to participate in, the relevant Consent Solicitation before the deadlines specified above. The deadlines set by any such intermediary and each Clearing System for the submission and revocation of Consent Instructions may be earlier than the relevant deadlines specified above.

 

No consent fee will be payable in connection with the Consent Solicitations.

Capitalised terms used but not defined herein shall have the meanings set out in the Consent Solicitation Memorandum.

Further information relating to the Consent Solicitation can be obtained directly from the Solicitation Agent and the Tabulation Agent:

 

Lloyds Bank Corporate Markets plc

10 Gresham Street

London EC2V 7AE

United Kingdom

Telephone: +44 20 7158 1719/1726

Attention: Liability Management Team

Email: liability.management@lloydsbanking.com

 

Lucid Issuer Services Limited

Tankerton Works

12 Argyle Walk

London WC1H 8HA

United Kingdom

Telephone: +44 20 7704 0880

Attention: Arlind Bytyqi

Email:lloydsbank@lucid-is.com

DISCLAIMER: This announcement must be read in conjunction with the Consent Solicitation Memorandum. The Consent Solicitation Memorandum contains important information which should be read carefully before any decision is made with respect to the consent solicitation. If any Securityholder is in any doubt as to the action it should take or is unsure of the impact of the implementation of the relevant Extraordinary Resolution, it is recommended to seek its own financial and legal advice, including in respect of any tax consequences, immediately from its broker, bank manager, solicitor, accountant, independent financial, tax or legal adviser. Any individual or company whose Securities are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee must contact such entity if it wishes to participate in the consent solicitation or otherwise participate in the relevant Meeting.

The distribution of the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession the Consent Solicitation Memorandum comes are required to inform themselves about, and to observe, any such restrictions.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSESSUUESSEIU
Date   Source Headline
25th Apr 20245:50 pmRNSTransaction in Own Shares
25th Apr 20241:14 pmRNSPublication of Suppl.Prospcts
24th Apr 20246:21 pmRNSTransaction in Own Shares
24th Apr 20242:37 pmRNSPublication of Suppl.Prospcts
24th Apr 202412:29 pmRNSPublication of Suppl.Prospcts
24th Apr 202411:03 amRNS2024 Q1 Interim Management Statement
24th Apr 20247:00 amRNS2024 Q1 Interim Management Statement
23rd Apr 20246:05 pmRNSTransaction in Own Shares
22nd Apr 20245:55 pmRNSTransaction in Own Shares
19th Apr 20245:41 pmRNSTransaction in Own Shares
18th Apr 20246:01 pmRNSTransaction in Own Shares
17th Apr 20246:10 pmRNSTransaction in Own Shares
16th Apr 20246:11 pmRNSTransaction in Own Shares
15th Apr 20245:59 pmRNSTransaction in Own Shares
12th Apr 20245:57 pmRNSTransaction in Own Shares
11th Apr 20245:37 pmRNSTransaction in Own Shares
11th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20246:02 pmRNSTransaction in Own Shares
9th Apr 20246:07 pmRNSTransaction in Own Shares
8th Apr 20246:02 pmRNSTransaction in Own Shares
4th Apr 20246:05 pmRNSTransaction in Own Shares
4th Apr 202410:10 amRNSPublication of Final Terms
3rd Apr 20246:01 pmRNSTransaction in Own Shares
2nd Apr 20245:56 pmRNSTransaction in Own Shares
28th Mar 20245:46 pmRNSTransaction in Own Shares
28th Mar 20245:39 pmRNSTotal Voting Rights
28th Mar 20245:24 pmRNSPublication of a Prospectus
28th Mar 20249:30 amRNSBlock Listing of Shares
27th Mar 20246:10 pmRNSTransaction in Own Shares
26th Mar 20245:53 pmRNSTransaction in Own Shares
26th Mar 20242:00 pmRNSDirector/PDMR Shareholding
25th Mar 20245:34 pmRNSTransaction in Own Shares
22nd Mar 20246:14 pmRNSPublication of a Prospectus
21st Mar 20246:13 pmRNSTransaction in Own Shares
21st Mar 20244:28 pmRNSNotice of AGM
20th Mar 20246:16 pmRNSTransaction in Own Shares
19th Mar 20246:18 pmRNSTransaction in Own Shares
18th Mar 20246:19 pmRNSTransaction in Own Shares
15th Mar 20246:05 pmRNSTransaction in Own Shares
15th Mar 20242:00 pmRNSDirector/PDMR Shareholding
14th Mar 20245:58 pmRNSTransaction in Own Shares
13th Mar 20246:23 pmRNSTransaction in Own Shares
13th Mar 20243:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:16 pmRNSTransaction in Own Shares
11th Mar 20246:16 pmRNSTransaction in Own Shares
8th Mar 20245:33 pmRNSTransaction in Own Shares
8th Mar 20241:30 pmRNSDirector/PDMR Shareholding
7th Mar 20246:06 pmRNSTransaction in Own Shares
7th Mar 20242:29 pmRNSDirector/PDMR Shareholding
6th Mar 20246:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.